Advertisement

Skin Cancer pp 165-172 | Cite as

Pathology of Other Skin Cancer

  • Feliciano Baldi
  • Angeles Fortuño-Mar
  • Alexander Bianchi
  • Alfredo D’Avino
  • Alfonso BaldiEmail author
Chapter
Part of the Current Clinical Pathology book series (CCPATH)

Abstract

In this chapter, we will focus on two malignant skin tumors: Merkel cell carcinoma and dermatofibrosarcoma protuberans (DFSP). The histogenesis, epidemiology, pathology, clinical features, diagnosis, and therapy of both tumors will be illustrated.

Keywords

Merkel Cell Carcinoma Nodular Fasciitis Dermatofibrosarcoma Protuberans Small Round Blue Cell Neuroendocrine Granule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Glossary

CD34

Glycoproteins found on immature hematopoietic cells and endothelial cells

Cytokeratin

Any of a class of fibrous proteins that are intermediate filaments present usually in pairs chiefly in epithelial cells and that are sometimes used as markers to identify malignancies of epithelial origin

Nerve growth factor receptor

Any of a family of plasma membrane integral proteins that bind nerve growth factors

Neuroendocrine tumor

A tumor that forms from cells that release hormones in response to a signal from the nervous system

Soft tissue sarcoma

A malignant tumor that begins in the muscle, fat, fibrous tissue, blood vessels, or other “soft” supporting tissues of the body

References

  1. 1.
    Darier J, Ferrand M. Dermatofibromes progressifs et recidivants ou fibrosarcomes de la peau. Ann Dermatol Syphiliga. 1924;5:545–62.Google Scholar
  2. 2.
    Haycox CL, Odland PB, Olbricht SM, Piepkorn M. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment. J Am Acad Dermatol. 1997;37:438–44.PubMedCrossRefGoogle Scholar
  3. 3.
    Chang CK, Jacobs IA, Salti GI. Outcomes of surgery for dermatofibrosarcoma protuberans. Eur J Surg Oncol. 2004;30(3):341–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol. 1995;164(1):129–34.PubMedCrossRefGoogle Scholar
  5. 5.
    Gloster HM. Dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35:355–74.PubMedCrossRefGoogle Scholar
  6. 6.
    Criscione VD, Weinstock MA. Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. J Am Acad Dermatol. 2007;56(6):968–73. Epub 2006 Dec 1.PubMedCrossRefGoogle Scholar
  7. 7.
    Taylor HB, Helwig EB. Dermatofibrosarcoma protuberans: a study of 115 cases. Cancer. 1962;15:717–25.PubMedCrossRefGoogle Scholar
  8. 8.
    McKee PH, Fletcher CD. Dermatofibrosarcoma protuberans in infancy and childhood. J Cutan Pathol. 1991;18:241–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Bowne WB, Antonescu CR, Leung DH, Katz SC, Hawkins WG, Woodruff JM, et al. Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer. 2000;88(12):2711–20.PubMedCrossRefGoogle Scholar
  10. 10.
    Abeloff MD. Abeloff’s clinical oncology. 4th ed. Philadelphia: Elsevier; 2008: Ch 74; Dupree WB, Langloss JW, Weiss SW. Pigmented dermatofibrosarcoma protuberans (Bednar tumor): a pathologic, ultrastructural and immunohistochemical study. Am J Surg Pathol. 1985;9:630–9.Google Scholar
  11. 11.
    Klijanienko J, Caillaud JM, Lagacé R. Fine-needle aspiration of primary and recurrent dermatofibrosarcoma protuberans. Diagn Cytopathol. 2004;30(4):261–5; Haycox CL, Odland PB, Olbricht SM, Piepkorn M. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment. J Am Acad Dermatol. 1997;37(3 Pt 1):438–44.Google Scholar
  12. 12.
    Abenoza P, Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol. 1993;15(5):429–34.PubMedCrossRefGoogle Scholar
  13. 13.
    Pedeutour F, Simon MP, Minoletti F, et al. Ring 22 chromosomes in dermatofibrosarcoma protuberans are low level amplifiers of chromosome 17 and 22l sequences. Cancer Res. 1995;55:2400–3.PubMedGoogle Scholar
  14. 14.
    Bridge JA, Neff JR, Sanberg AA. Cytogenetic analysis of dermatofibrosarcoma protuberans. Cancer Genet Cytogenet. 1990;49:199–202.PubMedCrossRefGoogle Scholar
  15. 15.
    No authors listed. Soft tissue sarcoma. In: Greene PL, Page DL, Fleming ID, editors. AJCC cancer staging manual. 6th ed. New York: Verlag; 2002. pp. 193–200.Google Scholar
  16. 16.
    Arnaud EJ, Perrault M, Revol M, Servant JM, Banzet P. Surgical treatment of dermatofibrosarcoma protuberans. Plast Reconstr Surg. 1997;100(4):884–95.PubMedGoogle Scholar
  17. 17.
    Paradisi A, Abeni D, Rusciani A, Cigna E, Wolter M, Scuderi N, et al. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery. Cancer Treat Rev. 2008;34(8):728–36.PubMedCrossRefGoogle Scholar
  18. 18.
    Briggaman RA, Wheeler CEJ. The epidermal-dermal junction. J Invest Dermatol. 1975;65:71–84.PubMedCrossRefGoogle Scholar
  19. 19.
    Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105:107–10.PubMedCrossRefGoogle Scholar
  20. 20.
    Tang CK, Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer. 1978;42:2311–21.PubMedCrossRefGoogle Scholar
  21. 21.
    Johannessen JV, Gould VE. Neuroendocrine skin carcinoma associated with calcitonin production: a Merkel cell carcinoma? Hum Pathol. 1980;11:586–8.PubMedGoogle Scholar
  22. 22.
    Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2005;89:1–4.PubMedCrossRefGoogle Scholar
  23. 23.
    Boyle F, Pendlebury S, Bell D. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys. 1995;31:315–23.PubMedCrossRefGoogle Scholar
  24. 24.
    Tai PT, Yu E, Winquist E, Hammond A, Stitt L, Tonita J, et al. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol. 2000;18:2493–9.PubMedGoogle Scholar
  25. 25.
    Koljonen V, Bohling T, Granhroth G, Tukiainen E. Merkel cell carcinoma: a clinicopathiological study of 34 patients. Eur J Surg Oncol. 2003;29:607–10.PubMedCrossRefGoogle Scholar
  26. 26.
    Connelly TJ, Cribier B, Brown TJ, Yanguas I. Complete spontaneous regression of Merkel cell carcinoma: a review of the 10 reported cases. Dermatol Surg. 2000;26:853–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Haag ML, Glass LF, Fenske NA. Merkel cell carcinoma. Diagnosis and treatment. Dermatol Surg. 1995;21:669–83.PubMedGoogle Scholar
  28. 28.
    Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol. 1995;8:384–8.PubMedGoogle Scholar
  29. 29.
    Leong AS, Phillips GE, Pieterse AS, Milios J. Criteria for the diagnosis of primary endocrine carcinoma of the skin (Merkel cell carcinoma). A histological, immunohistochemical and ultrastructural study of 13 cases. Pathology. 1986;18:393–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Van Gele M, Leonard JH, Van Roy N, Van Limbergen H, Van Belle S, Cacquyt V, et al. Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma. Int J Cancer. 2002;101:137–45.PubMedCrossRefGoogle Scholar
  31. 31.
    Larramendy ML, Koljonen V, Bohling T, Tukiainen E, Knuutila S. Recurrent DNA copy number changes revealed by comparative genomic hybridization in primary Merkel cell carcinomas. Mod Pathol. 2004;17:561–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Linjawi A, Jamison WB, Meterissian S. Merkel cell carcinoma: important aspects of diagnosis and management. Am Surg. 2001;67:943–7.PubMedGoogle Scholar
  33. 33.
    Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma. Prognosis and management. Arch Surg. 1991;126:1514–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Brisset AE, Olsen KD, Kasperbauer JL, Lewis JE, Goellner JR, Spotts BE, et al. Strome se: Merkel cell carcinoma of the head and neck: a retrospective case series. Head Neck. 2002;24:982–8.CrossRefGoogle Scholar
  35. 35.
    Kolsonen V. Merkel cell carcinoma. World J Surg Oncol 2006;4:7Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Feliciano Baldi
    • 1
  • Angeles Fortuño-Mar
    • 2
  • Alexander Bianchi
    • 1
  • Alfredo D’Avino
    • 1
  • Alfonso Baldi
    • 3
    • 4
    Email author
  1. 1.Department of Biochemistry, Section of PathologySecond University of NaplesNaplesItaly
  2. 2.Eldine Patologia LaboratoryValls, TarragonaSpain
  3. 3.Department of Environmental, Biological and Pharmaceutical Sciences and TechnologiesSecond University of NaplesNaplesItaly
  4. 4.Futura-onlusRomeItaly

Personalised recommendations